Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Ann Surg Oncol27 Feb 2024

Medicaid Expansion Increases Access for PDAC Patients in Southern States

Medicaid Expansion in southern states significantly increased insurance access for underserved groups with pancreatic ductal adenocarcinoma (PDAC). Expanded states had a 36% higher odds of Medicaid insurance and increased proportions of insured black, rural, and impoverished patients. However, the odds of receiving radiation therapy decreased…

HPB (Oxford)27 Feb 2024

Long-term Mortality Risk in Total Pancreatectomy Patients with Islet Autotransplant

Total pancreatectomy with islet autotransplant (TPIAT) for pancreatitis patients has a 10-year survival rate of 85.2% and a 15-year rate of 76.2%. Most deaths (53 out of 89) were possibly related to TPIAT, with causes including chronic gastrointestinal issues, malnutrition, and diabetes. Younger age, longer…

Ann Med25 Feb 2024

Advances in Targeted Therapy for Cholangiocarcinoma Patients

Research highlights the poor 5-year survival rates post-surgical resection for cholangiocarcinoma patients and the effectiveness of gemcitabine combined with platinum as first-line chemotherapy for advanced cases. Targeted therapy shows promise, but challenges include adverse reactions, drug resistance, and individual differences. The study emphasizes the need…

J Gastrointest Surg24 Feb 2024

Crucial Prognostic Factors in Ampullary Cancer: Nodal Staging and Lymph Node Examination

Patients with ampullary cancer benefit from examination of a minimum of 20 lymph nodes to accurately predict prognosis and minimize stage migration. The log odds transformation nodal classification scheme showed the highest accuracy in differentiating survival outcomes. Additionally, nodal metastasis in regional lymph nodes is…

Am J Surg23 Feb 2024

Does palliative surgery improve outcomes in locally advanced pancreatic cancer?

Patients with locally advanced pancreatic cancer undergoing palliative surgery experienced slightly longer survival than those undergoing medical palliation, with hospital stays and readmission rates being significantly higher for the surgical group. Despite the marginal survival benefit, palliative surgery presents challenges in terms of hospitalization and…